生命科学资讯

Potential Eylea competitor disappoints; FDA to review Moderna’s flu vaccine; Another rare disease rejection; and more

Vanda gets FDA approval for ‘franchise-extending’ antipsychotic

Grail's cancer test faces new uncertainty after UK study

Ionis scraps Alzheimer’s drug for people with Down syndrome

Supreme Court tariff ruling lets stand Trump’s authority to target pharma

Candel prices offering, signs royalty deal; Calquence label expands

Daiichi taps John Tsai to lead R&D as Ken Takeshita departs

Novartis to divest India unit to private equity-led consortium for $159M

Sanofi appoints specialty care head; Biogen chair to retire in June

Grail's cancer test misses primary study goal in UK study

AbbVie, PhRMA can proceed with 340B case in Hawaii

When a health tech startup gets stuck in regulatory limbo

Teva beats Corcept in appeals fight over generic Cushing's syndrome drug

FDA formalizes one pivotal trial policy via NEJM perspective

Obesity biotech Verdiva plans big year of data, explores deals

Biogen stops part of an MS trial; Merck reports more Enflonsia data

Sanofi to expand in India; Stada invests $100M in Saudi Arabia

Hims to buy Australia’s Eucalyptus for $240M upfront in global push

Altesa raises $75M for oral respiratory med

J&J pauses patient recruitment in mid-stage trial of AC Immune’s Alzheimer’s drug